Clients
hVIVO plc (formerly Open Orphan plc)
hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
The Company expects to announce a trading update for the year ended 31 December 2024 before the end of February 2025, which will include the outlook for 2025.
Investors can sign up to Investor Meet Company for free and add to meet hVIVO plc via: https://www.investormeetcompany.com/companies/hvivo-plc-1| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | April |
| Interim Results* | September |
| AGM* | May |
* Months based on previous announcements of this kind
hVIVO Investor Presentation - Sept 2024
---two-page-company-summary-(march-2024).png "hVIVO (AIM HVO) - Two page Company summary (March 2024)")
hVIVO (AIM HVO) - Two page company summary (March 2024)
Who We Work With
hVIVO plc (formerly Open Orphan plc)
hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
The Company expects to announce a trading update for the year ended 31 December 2024 before the end of February 2025, which will include the outlook for 2025.
Investors can sign up to Investor Meet Company for free and add to meet hVIVO plc via: https://www.investormeetcompany.com/companies/hvivo-plc-1| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | April |
| Interim Results* | September |
| AGM* | May |
* Months based on previous announcements of this kind
hVIVO Investor Presentation - Sept 2024
hVIVO (AIM HVO) - Two page company summary (March 2024)
Leave a comment